By Paul A. Harris
Portland, Ore., July 30 – Iqvia Inc. priced a €720 million issue of senior notes due Jan. 15, 2028 (Ba3/BB) at par to yield 2¼% on Tuesday, according to market sources.
The yield priced tighter than both the official talk, which was set in the 2½% area, and initial price talk of 2½% to 2¾%.
The deal was launched in to the market as an $800 million equivalent offering of euro-denominated notes.
Goldman Sachs & Co. LLC, Barclays, BofA Securities Inc., HSBC Securities (USA) Inc., J.P. Morgan Securities LLC and Wells Fargo Securities LLC were the joint bookrunners.
The Durham, N.C.-based provider of health information technologies and clinical research plans to use the proceeds to redeem its 4 7/8% notes due May 2023 originally issued by Quintiles Transnational Corp.
| Issuer: | Iqvia Inc.
|
| Amount: | €720 million
|
| Maturity: | Jan. 15, 2028
|
| Securities: | Senior notes
|
| Bookrunners: | Goldman Sachs & Co. LLC, Barclays, BofA Securities Inc., HSBC Securities (USA) Inc., J.P. Morgan Securities LLC and Wells Fargo Securities LLC
|
| Coupon: | 2¼%
|
| Price: | Par
|
| Yield: | 2¼%
|
| First call: | July 15, 2022 at 101.125
|
| Trade date: | July 30
|
| Settlement date: | Aug. 13
|
| Ratings: | Moody's: Ba3
|
| S&P: BB
|
| Distribution: | Rulle144A and Regulation S
|
| Price talk: | 2½% area
|
| Marketing: | Roadshow
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
